CTSO
Cytosorbents Corporation - Common Stock (CTSO)
$62
About Cytosorbents Corporation - Common Stock (CTSO)
CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin in August 1997 and is headquartered in Princeton, NJ.
Details
Daily high
$4.68
Daily low
$4.11
Price at open
$4.25
52 Week High
$17.00
52 Week Low
$2.84
Market cap
14.4M
Dividend yield
-
Volume
17,843
Avg. volume
73,655
P/E ratio
-.79
Cytosorbents Corporation - Common Stock News
Details
Daily high
$4.68
Daily low
$4.11
Price at open
$4.25
52 Week High
$17.00
52 Week Low
$2.84
Market cap
14.4M
Dividend yield
-
Volume
17,843
Avg. volume
73,655
P/E ratio
-.79